nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A prognostic score for acute graft-versus-host disease based on biomarkers: a multicentre study
|
Levine, John E |
|
2015 |
2 |
1 |
p. e21-e29 nvt p. |
artikel |
2 |
Association between metformin use and progression of monoclonal gammopathy of undetermined significance to multiple myeloma in US veterans with diabetes mellitus: a population-based retrospective cohort study
|
Chang, Su-Hsin |
|
2015 |
2 |
1 |
p. e30-e36 nvt p. |
artikel |
3 |
Biomarkers for GVHD prognosis
|
Betts, Brian |
|
2015 |
2 |
1 |
p. e4-e5 nvt p. |
artikel |
4 |
Interferon in CML: back to the past, or towards the future?
|
Soverini, Simona |
|
2015 |
2 |
1 |
p. e8-e9 nvt p. |
artikel |
5 |
Nilotinib and peginterferon alfa-2a for newly diagnosed chronic-phase chronic myeloid leukaemia (NiloPeg): a multicentre, non-randomised, open-label phase 2 study
|
Nicolini, Franck E |
|
2015 |
2 |
1 |
p. e37-e46 nvt p. |
artikel |
6 |
Rare and difficult to treat haematological diseases
|
The Lancet Haematology, |
|
2015 |
2 |
1 |
p. e1- 1 p. |
artikel |
7 |
Risk of progression in MGUS
|
Rajkumar, S Vincent |
|
2015 |
2 |
1 |
p. e6-e7 nvt p. |
artikel |
8 |
Sequential azacitidine and lenalidomide in patients with high-risk myelodysplastic syndromes and acute myeloid leukaemia: a single-arm, phase 1/2 study
|
DiNardo, Courtney D |
|
2015 |
2 |
1 |
p. e12-e20 nvt p. |
artikel |
9 |
56th American Society of Hematology Annual Meeting
|
Smith, Lan-Lan |
|
2015 |
2 |
1 |
p. e10-e11 nvt p. |
artikel |
10 |
Treating myelodysplastic syndromes: is more better?
|
Sekeres, Mikkael A |
|
2015 |
2 |
1 |
p. e2-e3 nvt p. |
artikel |